Kevin P. Kerns

Array ( [id] => 5521380 [patent_doc_number] => 20090029361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'GROWTH DIFFERENTIATION FACTOR-7' [patent_app_type] => utility [patent_app_number] => 11/939387 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7624 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029361.pdf [firstpage_image] =>[orig_patent_app_number] => 11939387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812751 [patent_doc_number] => 20080193382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Methods and Compositions for the Treatment of Sterile Inflammation' [patent_app_type] => utility [patent_app_number] => 11/937949 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11447 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193382.pdf [firstpage_image] =>[orig_patent_app_number] => 11937949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501507 [patent_doc_number] => 20110263510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Methods of Inhibiting Cell Death or Inflammation in a Mammal' [patent_app_type] => utility [patent_app_number] => 12/514436 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25467 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263510.pdf [firstpage_image] =>[orig_patent_app_number] => 12514436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676148 [patent_doc_number] => 20080213778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses' [patent_app_type] => utility [patent_app_number] => 11/983233 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 76029 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213778.pdf [firstpage_image] =>[orig_patent_app_number] => 11983233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563653 [patent_doc_number] => 20090136505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Intranasal Administration of Active Agents to the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 11/931201 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17006 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136505.pdf [firstpage_image] =>[orig_patent_app_number] => 11931201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121191 [patent_doc_number] => 07709217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Modified human thymic stromal lymphopoietin' [patent_app_type] => utility [patent_app_number] => 11/981423 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709217.pdf [firstpage_image] =>[orig_patent_app_number] => 11981423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228804 [patent_doc_number] => 20100183542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Synergism Between Activated Immune Cells and Conventional Cancer Therapies' [patent_app_type] => utility [patent_app_number] => 12/447027 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 7245 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183542.pdf [firstpage_image] =>[orig_patent_app_number] => 12447027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412604 [patent_doc_number] => 20100166760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHODS OF REDUCING PHOSPHATE ABSORPTION' [patent_app_type] => utility [patent_app_number] => 12/447385 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10069 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166760.pdf [firstpage_image] =>[orig_patent_app_number] => 12447385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899321 [patent_doc_number] => 20080118935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSING NEOPLASTIC DISEASE' [patent_app_type] => utility [patent_app_number] => 11/869686 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14271 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118935.pdf [firstpage_image] =>[orig_patent_app_number] => 11869686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318825 [patent_doc_number] => 07521535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Anti-microbial defensin-related peptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/857048 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9645 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521535.pdf [firstpage_image] =>[orig_patent_app_number] => 11857048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6419373 [patent_doc_number] => 20100150834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'HIGH AFFINITY EPHB RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/441274 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 62494 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150834.pdf [firstpage_image] =>[orig_patent_app_number] => 12441274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921985 [patent_doc_number] => 20080070300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Human chemotactic cytokine' [patent_app_type] => utility [patent_app_number] => 11/900700 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25669 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070300.pdf [firstpage_image] =>[orig_patent_app_number] => 11900700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62253 [patent_doc_number] => 07763242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate' [patent_app_type] => utility [patent_app_number] => 11/899747 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 50583 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763242.pdf [firstpage_image] =>[orig_patent_app_number] => 11899747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292202 [patent_doc_number] => 07544491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'TANGO 240 nucleic acids and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/900016 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 41664 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544491.pdf [firstpage_image] =>[orig_patent_app_number] => 11900016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728569 [patent_doc_number] => 08101183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Variable region sequences of IL-31 monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/850006 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 55282 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101183.pdf [firstpage_image] =>[orig_patent_app_number] => 11850006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126626 [patent_doc_number] => 08574572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Method of treating pulmonary disease by administering an antibody to G-CSF receptor' [patent_app_type] => utility [patent_app_number] => 12/377256 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18701 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12377256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301920 [patent_doc_number] => 20120184485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'USES OF CYSTATIN' [patent_app_type] => utility [patent_app_number] => 12/376318 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8862 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12376318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497453 [patent_doc_number] => 07919095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Anti-IL-6 monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/882751 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 27145 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 314 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919095.pdf [firstpage_image] =>[orig_patent_app_number] => 11882751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493610 [patent_doc_number] => 07947265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Fusion proteins and methods for modulation of immune response' [patent_app_type] => utility [patent_app_number] => 12/375730 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18508 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947265.pdf [firstpage_image] =>[orig_patent_app_number] => 12375730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464390 [patent_doc_number] => 20090324590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'MYOSTATIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/376289 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21026 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324590.pdf [firstpage_image] =>[orig_patent_app_number] => 12376289 [rel_patent_id] =>[rel_patent_doc_number] =>)